{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:37:00Z","timestamp":1792417020762,"version":"4.4.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The accurate preoperative prediction of lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC) poses a significant clinical challenge. Although clinicopathological features are commonly utilized, their predictive accuracy remains limited, and the role of multi-gene co-mutations is not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to develop and validate an integrated risk model that combines next-generation sequencing (NGS) data with clinicopathologic features for the preoperative prediction of LNM in PTC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 521 patients with PTC. Gene mutations were analyzed using NGS. Independent risk factors for central (CLNM) and lateral (LLNM) lymph node metastasis were identified through univariate and multivariate logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>BRAF<\/jats:italic>\n                      V600E mutation was the most prevalent (82.15%). Notably, high-risk multi-gene co-mutations\n                      <jats:bold>\u2014<\/jats:bold>\n                      specifically,\n                      <jats:italic>BRAF<\/jats:italic>\n                      V600E co-occurring with\n                      <jats:italic>TERT<\/jats:italic>\n                      ,\n                      <jats:italic>PIK3CA<\/jats:italic>\n                      , and\/or\n                      <jats:italic>TP53<\/jats:italic>\n                      )\n                      <jats:bold>\u2014<\/jats:bold>\n                      were identified as the strongest independent risk factor for CLNM (odds ratio [OR] = 6.319, 95% confidence interval [CI]: 1.738\u201322.976, P = 0.005). Other significant risk factors included male sex, age &amp;lt;45 years, bilateral lesions, tumor size &amp;gt;1 cm, lymphovascular invasion (LVI), and extrathyroidal extension,with gross ETE demonstrating the highest ORs (&amp;gt; 21).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preoperative NGS profiling, particularly the detection of high-risk multi-gene co-mutations, provides a powerful tool for refined risk assessment. This molecularly guided strategy has the potential to inform personalized surgical planning directly, optimizing the extent of lymph node dissection to improve oncologic outcomes while minimizing unnecessary morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1728045","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:42:30Z","timestamp":1769496150000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Qing","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pathology, Deyang People\u2019s Hospital","place":["Deyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Deyang People\u2019s Hospital","place":["Deyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","article-title":"Thyroid cancer: incidence and mortality trends in China 2005-2015","volume":"68","author":"Wang","year":"2020","journal-title":"Endocrine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.906695","article-title":"A narrative review of preventive central lymph node dissection in patients with papillary thyroid cancer: a necessity or an excess","volume":"12","author":"Dolidze","year":"2022","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"107305","DOI":"10.1016\/j.ejso.2023.107305","article-title":"Long-term impact of prophylactic central neck dissection in non-invasive classic papillary thyroid carcinoma","volume":"50","author":"Xu","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12957-021-02247-w","article-title":"Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study","volume":"19","author":"Li","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/0194599820966995","article-title":"Association between age and nodal metastasis in papillary thyroid carcinoma","volume":"165","author":"Shukla","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1353923","article-title":"Factors associated with occult lateral lymph node metastases in patients with clinically lymph node negative papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"15","author":"Fei","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","article-title":"Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers","volume":"24","author":"Pozdeyev","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e250033","DOI":"10.6004\/jnccn.2025.0033","article-title":"NCCN Guidelines\u00ae Insights: Thyroid Carcinoma, Version 1.2025","volume":"23","author":"Haddad","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41467-018-03033-1","article-title":"Regulation of mutant TERT by BRAF V600E\/MAP kinase pathway through FOS\/GABP in human cancer","volume":"9","author":"Liu","year":"2018","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41574-023-00920-6","article-title":"Genomic alterations in thyroid cancer: biological and clinical insights","volume":"20","author":"Landa","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/cen.13413","article-title":"Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma\u2014A meta-analysis","volume":"87","author":"Vuong","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and clinical perspectives on thyroid cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1584618","article-title":"Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma","volume":"16","author":"Liu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/cancers17060939","article-title":"Prognostic significance of key molecular markers in thyroid cancer: a systematic literature review and meta-analysis","volume":"17","author":"Nguyen","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1089\/thy.2020.0086","article-title":"Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases","volume":"30","author":"Xu","year":"2020","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/JOE-17-0266","article-title":"Key signaling pathways in thyroid cancer","volume":"235","author":"Zaballos","year":"2017","journal-title":"J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3877\/cma.j.issn.1674-0793.2020.03.001","article-title":"Guangdong expert consensus on genetic testing and clinical application for thyroid cancer (2020 version)","volume":"14","year":"2020","journal-title":"Chin Arch Gen Surg (Electr Ed)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1006239","DOI":"10.1371\/journal.pgen.1006239","article-title":"Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers","volume":"12","author":"Yoo","year":"2016","journal-title":"PLoS Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/curroncol32060315","article-title":"Unraveling racial disparities in papillary thyroid cancer: A comparative bulk RNA-sequencing gene expression analysis","volume":"32","author":"Barseghyan","year":"2025","journal-title":"Curr Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21037\/gs-20-482","article-title":"Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma","volume":"9","author":"Song","year":"2020","journal-title":"Gland Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijsu.2017.12.029","article-title":"Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis for prevalence, risk factors, and location","volume":"50","author":"So","year":"2018","journal-title":"Int J Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e5794","DOI":"10.1097\/MD.0000000000005794","article-title":"Prognostic impact of minimal extrathyroidal extension in papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"95","author":"Yin","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1108125","article-title":"Predictive nomogram for central lymph node metastasis in papillary thyroid microcarcinoma based on pathological and ultrasound features","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40644-023-00568-5","article-title":"Nomogram for preoperative estimation risk of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a multicenter study","volume":"23","author":"Zhu","year":"2023","journal-title":"Cancer Imaging"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1016\/j.ejso.2021.08.033","article-title":"A prediction model incorporating the BRAF V600E protein status for determining the risk of cervical lateral lymph node metastasis in papillary thyroid cancer patients with central lymph node metastasis","volume":"47","author":"Liu","year":"2021","journal-title":"Eur J Surg Oncol"}],"updated-by":[{"DOI":"10.3389\/fendo.2026.1798213","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000}},{"DOI":"10.3389\/fendo.2026.1925037","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1728045\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:42:35Z","timestamp":1784731355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1728045\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":30,"alternative-id":["10.3389\/fendo.2025.1728045"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1728045","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1728045"}}